I The effects of single intravenous doses of diazepam, clonazepam, lorazepam, frusemide, mexiletine and (+)-propranolol on the frequency of electroencephalographic (EEG) interictal spike discharges were assessed in three double-blind placebo-controlled trials in fourteen epileptic patients. 2 Diazepam (5 mg) produced a significant mean decrease of spike discharges to about one third of the control frequency. The effect developed rapidly and persisted for the duration of the study (up to 25 min after injection). A larger dose (10 mg) failed to produce a further reduction in the frequency of the spike discharges. 3 Clonazepam (0.5 mg), frusemide (40 mg) and lorazepam (2 mg) appeared to be as effective as diazepam in reducing spike discharges, although the effect of the latter drug seemed to develop with some delay. 4 Mexiletine (100 mg) and (+)-propranolol (50 mg) did not reduce paroxysmal EEG discharges, their effects being not significantly different from that of saline. 5 EEG spike counting after intravenous administration of single test-doses appeared to be both a simple and promising technique for the rapid preliminary evaluation of the clinical efficacy of new antiepileptic drugs.
Introduction
A proportion of patients with epilepsy, particularly those who have frequent fits, show interictal electroencephalographic (EEG) abnormalities. These comprise spike and wave complexes, polyspikes, sharp waves and slow waves which may be diffuse, bilateral or focal in distribution. Apart from being of diagnostic value, these abnormalities can be used for assessing the potential antiepileptic activity of a drug. As these EEG signs are an expression of discharges occurring in the grey matter which are responsible for the clinical manifestations of epileptic seizures, it is reasonable to assume that agents able to reduce or suppress such abnormalities might have antiepileptic activity. Although attempts to find a correlation between improvement of interictal EEGs and the efficacy of chronic antiepileptic therapy have proved disappointing, particularly with carbamazepine (Rodin, Rim & Renwick, 1974) , the evaluation of the EEG response to single test doses given parenterally may provide an alternative approach. Single intravenous doses of diazepam or clonazepam, both of which are established antiepileptic agents, can reduce or abolish paroxysmal discharges and interictal spikes (Niedermayer, 1970; Booker & Celesia, 1973; Haikkinen, 1973 ) and a clear relationship between the serum concentration of diazepam and the resulting depression of spike discharges has been demonstrated (Booker & Celesia, 1973) .
Recently, new drugs have been developed which have shown anticonvulsant properties in animal studies. Among these, lorazepam, a new benzodiazepine used as an anxiolytic drug, (+)-propranolol, an isomer of propranolol with very weak f6-adrenoceptor blocking activity, and mexiletine, a new cardiac antidysrhythmic drug, have all proved active against both chemically and electrically induced seizures in animals (Gluckman, 1971; Murmann, Almirante & Saccani-Guelfi, 1966; Leszkovszky & Tardos, 1965; Cereghino, Wilder, Kupferberg, Yorekawa, Perchalski, Ramsey, White, Perry & Smith, 1975) .
In a recent placebo-controlled clinical trial, frusemide, added to pre-existing treatment, improved seizure control, although a slight but significant rise in phenobarbitone serum levels which occurred during diuretic treatment led to uncertainties in interpretation of results (Ahmad, Clarke, Hewett & Richens, 1976 
Methods
Fourteen epileptic patients, eight men and six women aged 16-38 years and resident at the Chalfont Centre for Epilepsy, gave their informed consent to take part in the trial. They were selected because they showed spontaneous, frequent (range 1-300/min) and persistent spike, polyspike, and spike and wave interictal EEG discharges. These discharges were diffuse in one subject, focal temporal in eleven subjects, and focal frontal in two subjects. All the patients were receiving anticonvulsant treatment, usually a combination of phenytoin with phenobarbitone or primidone. The patients were divided into three groups of six subjects each, two patients being included in both groups 1 and 2, and one patient being included in all three groups. Each subject in group 1 received on separate occasions single intravenous doses of diazepam (5 mg), mexiletine (100 mg), (+)-propranolol (50 mg) and saline (1 ml). Subjects in group 2 received diazepam (10mg), frusemide (40mg) and saline. Subjects in group 3 received diazepam (5 mg), clonazepam (0.5 mg), lorazepam (2 mg) and saline. The study was performed on a double-blind basis and the order of treatment was randomized, the interval between the treatments averaging 1 week. Each drug was administered intravenously over a period of 1 minute. EEGs were recorded for 10 min prior to administration of the drug, for 10 min immediately after the injection and again from 15-25 min after the injection. They were not performed when patients were in a post-ictal state following a tonic-clonic fit, although the occurrence of minor fits shortly before the recording were ignored. EEGs were recorded with pad electrodes on an eight channel SLE Galileo (Model E8B) electroencephalograph recorder. The electrodes were placed according to the 10-20 system, and recordings were generally made from the lateral ring of electrodes although occasionally an alternative montage was used in order to obtain optimal recording of focal spikes. Spikes were counted manually in one lead in which the spikes were most clearly defined. Reference was usually made to adjacent leads on the same side of the head to confirm the presence of a spike when the focus was shifting.
When spikes appeared independently on both sides of the head, counting was confined to one side only. The criterion used for identifying a waveform as a 'spike' was based upon the commonly-accepted definition: a wave distinguished from background activity and having a duration of 1/12 s or less (Cooper, Osselton & Shaw, 1969) . Prior to counting, the records were scanned quickly in order that the rater could acquaint himself with the characteristics of each subject's spike discharges. The total number of spikes in each 10 min recording period was then counted and the percentage change with respect to the pre-injection period calculated. Occasionally, difficulty was encountered when these characteristics were modified by drug effects, but records in which this occurred were checked by a second rater. All records were assessed blind with respect to drug treatments; only the identity of the patient was revealed to the rater.
Pulse rate and supine blood pressure were recorded immediately before and again 10 min after the injection in the subjects who received (+)-propranolol, in order to determine whether this compound produced a P-adrenoceptor blocking effect. Diazepam, given intravenously in doses of 5 or 10 mg, produced a marked and significant decrease in spike frequency, which manifested itself during the first 10 min after the injection and remained unchanged during the successive period of observation (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) min after the injection) (Figures 1, 2 and 3) . The reduction was of the same magnitude in all groups, the spike frequency falling to 23 to 51% of the control response, in spite of the different subjects included in each group and of the larger dose (10 mg) administered to subjects in group 2 (Tables 1, 2 3). Only one out of fourteen subjects did not respond to diazepam. His EEG showed frequent (300/min) bilateral frontal discharges, which were not influenced by any of the drugs tested on him. Mexiletine and (+)-propranolol failed to reduce the frequency of spike discharges compared with the saline control ( Figure 1, Table 1 ). Frusemide (40 mg) produced a marked and sustained decrease in spike frequency, which was not statistically different from that produced by diazepam ( Figure 2 , Table 2 ). Clonazepam (0.5 mg) was also effective, showing similarity to diazepam with regard to time course and magnitude of effect ( Figure 3 , Table 3 ). Lorazepam appeared to decrease only Table 1 Spike count, heart rate and blood pressure in six epileptic patients after intravenous injection of diazepam (5 mg), mexiletine (100 mg) and (+)-propranolol (50 mg). The results given are the differences between the observations after an injection of saline and after an injection of the respective drug. Heart rate and blood pressure were measured 10 min after the injection. Results are given as mean values + 1 s.e. mean. slightly the spike discharges during the first 10 min after the injection. However, a marked decrease, similar to that produced by diazepam, was observed during the successive period of observation.
Heart rate and bloodpressure
In the first study, heart rate and blood pressure were recorded in order to look for a ,B-adrenoceptor blocking effect of (+)-propranolol. A significant bradycardia 10 min after injection suggested that some degree of blockade had occurred (Table 1) . Diazepam (5 mg) produced a significant reduction in systolic blood pressure at 10 minutes.
Discussion
The 'deactivating' effect of intravenous diazepam on paroxysmal EEG discharges in patients with epilepsy was examined in detail by Niedermeyer (1970) . Subsequently, Booker & Celesia (1973) counting the total number of EEG spikes over periods of 10 min and expressing the results as the percentage change with respect to the pre-injection period. Diazepam (5 mg), given intravenously over a period of 1 min, provided a valuable reference as it consistently produced a marked degree of reduction of interictal discharges. Only one of fourteen patients did not respond to diazepam, in spite of the large interindividual differences in the EEG abnormalities encountered in our subjects. Although we have not measured serum diazepam concentrations, they were probably lower than those reported by Booker & Celesia (1973) who administered a dose of 10 mg to their adult patients. However, in our experience the degree of inhibition of spike activity following a 10 mg dose was not statistically different from that produced by a 5 mg dose. Although it is possible that diazepam (5 mg) produces a maximal response, an alternative explanation is that the increased activity of a larger dose is counterbalanced by the 'activating' effect on spike discharges resulting from sedation.
The other benzodiazepines we have tested, clonazepam and lorazepam, proved to be effective in reducing interictal EEG discharges. The effect produced by clonazepam (0.5 mg) resembled closely the effect of diazepam (5 mg), which is in harmony with clinical experience on the dosage requirements of these two compounds. Clonazepam is now an established drug for the treatment of epilepsy and has been shown to be a valuable alternative to diazepam in status epilepticus (Gastaut, Courjon, Poire & Weber, 1971; Browne, 1976) . Lorazepam produced a similar but delayed response when compared with diazepam.
Lorazepam has been shown to have anticonvulsant properties in animal studies (Gluckman, 1971) but has not previously been tested as an anticonvulsant in man. Although extrapolation might be hazardous, our data suggests that this agent could be an effective antiepileptic drug, although its delayed onset of action could make it unsatisfactory in status epilepticus. The dose administered, 2 mg, is considered to be equivalent to diazepam 5 mg in terms of anxiolytic and hypnotic activity, and in our experiments it appeared to have an equivalent effect on spike discharges, although slower to develop.
In a recent controlled trial in patients with focal epilepsy, frusemide given orally for 4 weeks in a dose of 40 mg 8-hourly produced a significant reduction in focal fits (Ahmad et al., 1976 Drift, 1963) . Further evidence and the clinical implications of these findings are discussed elsewhere (Ahmad et al., 1976) .
Animal experiments have shown that (±)-propranolol, the racemic mixture used clinically as a /3-adrenoceptor blocking drug, possesses anticonvulsant activity (Murmann et al., 1966; Leszkovszky & Tardos, 1965 (Natu, Bose, Gandhi & Seth, 1968) . Furthermore, (+)-propranolol, which has weak P-adrenoceptor blocking activity compared with its (-)-isomer, has anticonvulsant effects in the rat which equal those of the racemic mixture (Greenwood (1974) , personal communication). However, (+)-propranolol failed to reduce the frequency of spikes in our patients, in spite of the fact that the dose used (50 mg) was sufficient to reduce significantly the heart rate, presumably through /3-adrenoceptor blockade.
The antiarrhythmic agent, mexiletine, has been shown to prevent chemically and electrically induced seizures in mice and initial clinical trials have given encouraging results (Wilder, Langlois & Hammer, 1973; Cereghino et al., 1975) . In our study, mexiletine did not reduce paroxysmal EEG discharges although it was given in doses which produced adverse effects. More information from clinical trials is needed before any conclusion on the efficacy of this drug can be drawn.
In conclusion, our results suggest that spike counting can provide a valuable method for the preliminary assessment of new antiepileptic drugs. The technique is simple, rapid, and relatively safe in that the total dose received by the patient can be small. The effectiveness of new drugs can be reproducibly compared with an established valuable reference agent (diazepam), and with a saline placebo. However, further studies are needed to determine its usefulness in providing a reliable indication of clinical efficacy. The technique can be applied only to drugs that can be given safely intravenously, and may give misleading information with drugs which cross the blood-brain barrier with difficulty so that their onset of action may be slow and delayed, or with drugs which are active wholly or partly by metabolite formation.
